205 related articles for article (PubMed ID: 10454717)
21. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
Allen JA; Scala S; Jones HR
Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
[TBL] [Abstract][Full Text] [Related]
22. Single fiber EMG as a prognostic tool in myasthenia gravis.
Baruca M; Leonardis L; Podnar S; Hojs-Fabjan T; Grad A; Jerin A; Blagus R; Šega-Jazbec S
Muscle Nerve; 2016 Dec; 54(6):1034-1040. PubMed ID: 27144873
[TBL] [Abstract][Full Text] [Related]
23. Single-fiber electromyography of masseter muscle in myasthenia gravis.
Khuraibet AJ; Rousseff RT; Behbehani R; al-Shubaili AF; Khan RA
Muscle Nerve; 2008 Apr; 37(4):522-5. PubMed ID: 17985370
[TBL] [Abstract][Full Text] [Related]
24. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
[TBL] [Abstract][Full Text] [Related]
25. [Single fiber electromyography in the diagnosis of myasthenia gravis].
Gómez-Fernández L; Vega-Treto H; Lestayo-Ofarril Z
Rev Neurol; 2000 Apr 1-15; 30(7):609-13. PubMed ID: 10859737
[TBL] [Abstract][Full Text] [Related]
26. Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.
Akan O; Baysal-Kirac L
Acta Neurol Belg; 2021 Oct; 121(5):1131-1140. PubMed ID: 33439450
[TBL] [Abstract][Full Text] [Related]
27. A comparison of electrodiagnostic tests in ocular myasthenia gravis.
Katzberg HD; Bril V
J Clin Neuromuscul Dis; 2005 Mar; 6(3):109-13. PubMed ID: 19078758
[TBL] [Abstract][Full Text] [Related]
28. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A
Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047
[TBL] [Abstract][Full Text] [Related]
29. Repetitive nerve stimulation in myasthenia gravis--relative sensitivity of different muscles.
Costa J; Evangelista T; Conceição I; de Carvalho M
Clin Neurophysiol; 2004 Dec; 115(12):2776-82. PubMed ID: 15546785
[TBL] [Abstract][Full Text] [Related]
30. Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.
Zimmermann CW; Eblen F
Clin Investig; 1993 Jun; 71(6):445-51. PubMed ID: 8353403
[TBL] [Abstract][Full Text] [Related]
31. Ocular Myasthenia Gravis: Toward a Risk of Generalization Score and Sample Size Calculation for a Randomized Controlled Trial of Disease Modification.
Wong SH; Petrie A; Plant GT
J Neuroophthalmol; 2016 Sep; 36(3):252-8. PubMed ID: 27031125
[TBL] [Abstract][Full Text] [Related]
32. Ocular myasthenia gravis: the diagnostic yield of repetitive nerve stimulation and stimulated single fiber EMG of orbicularis oculi muscle and infrared reflection oculography.
Oey PL; Wieneke GH; Hoogenraad TU; van Huffelen AC
Muscle Nerve; 1993 Feb; 16(2):142-9. PubMed ID: 8429837
[TBL] [Abstract][Full Text] [Related]
33. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
[TBL] [Abstract][Full Text] [Related]
34. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
[TBL] [Abstract][Full Text] [Related]
35. Inferior oblique muscle paresis as a sign of myasthenia gravis.
Almog Y; Ben-David M; Nemet AY
J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation.
Witoonpanich R; Dejthevaporn C; Sriphrapradang A; Pulkes T
Clin Neurophysiol; 2011 Sep; 122(9):1873-7. PubMed ID: 21419697
[TBL] [Abstract][Full Text] [Related]
37. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis.
Wang ZY; Okita DK; Howard J; Conti-Fine BM
Neurology; 1998 Apr; 50(4):1045-54. PubMed ID: 9566393
[TBL] [Abstract][Full Text] [Related]
38. Reliability of SFEMG in diagnosing myasthenia gravis: sensitivity and specificity calculated on 100 prospective cases.
Padua L; Caliandro P; Di Iasi G; Pazzaglia C; Ciaraffa F; Evoli A
Clin Neurophysiol; 2014 Jun; 125(6):1270-3. PubMed ID: 24296278
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population.
Aguirre F; Villa AM
Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of single fiber EMG for distinguishing neuromuscular from other causes of ocular muscle weakness.
Ukachoke C; Ashby P; Basinski A; Sharpe JA
Can J Neurol Sci; 1994 May; 21(2):125-8. PubMed ID: 8087737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
